You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

DS1062

Showing 1 - 25 of 82
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Hormone Receptor Positive Breast Cancer, Triple Negative Breast Cancer, NSCLC Trial in Japan, United States (Datopotamab

Recruiting
  • Hormone Receptor Positive Breast Cancer
  • +2 more
  • Datopotamab Deruxtecan (Dato-DXd)
  • Los Angeles, California
  • +13 more
Jun 21, 2022

Metastatic Lung Cancer Trial in Villejuif (DS-1062a)

Recruiting
  • Metastatic Lung Cancer
  • Villejuif, France
    Gustave Roussy
Jun 17, 2021

Breast Cancer Stage IV Trial in Vienna (Datopotamab deruxtecan)

Recruiting
  • Breast Cancer Stage IV
  • Datopotamab deruxtecan
  • Vienna, Austria
    AKH Universitaetsklinikum Vienna, Department f. Internal medicin
May 19, 2023

NSCLC, Triple Negative Breast Cancer Trial in China (Datopotamab Deruxtecan (Dato-DXd))

Recruiting
  • Carcinoma, Non-Small-Cell Lung
  • Triple Negative Breast Cancer
  • Datopotamab Deruxtecan (Dato-DXd)
  • Beijing, China
  • +27 more
Aug 11, 2022

NSCLC Trial in Worldwide (DS-1062a)

Active, not recruiting
  • Non-small Cell Lung Cancer
  • Phoenix, Arizona
  • +82 more
Jul 27, 2022

NSCLC Trial in Worldwide (Osimertinib, Savolitinib, Gefitinib)

Recruiting
  • Non-Small Cell Lung Cancer
  • Duarte, California
  • +52 more
Jan 19, 2023

Endometrial Cancer, Gastric Cancer, Metastatic Castration-resistant Prostate Cancer Trial in Worldwide (Datopotamab deruxtecan

Not yet recruiting
  • Endometrial Cancer
  • +4 more
  • Datopotamab deruxtecan (Dato-DXd)
  • +8 more
  • Los Angeles, California
  • +52 more
Aug 3, 2022

NSCLC Trial in Worldwide (DS-1062a, Docetaxel)

Recruiting
  • Non-small Cell Lung Cancer
  • Chandler, Arizona
  • +203 more
Jun 9, 2022

Breast Cancer Trial in Worldwide (Dato-DXd, Durvalumab, Paclitaxel)

Not yet recruiting
  • Breast Cancer
  • Duarte, California
  • +111 more
Oct 23, 2023

Breast Cancer Trial in Worldwide (Dato-DXd, Capecitabine, Gemcitabine)

Active, not recruiting
  • Breast Cancer
  • Duarte, California
  • +172 more
Dec 1, 2022

Breast Cancer Trial in Worldwide (Dato-DXd, Durvalumab, Pembrolizumab)

Not yet recruiting
  • Breast Cancer
  • Jonesboro, Arkansas
  • +142 more
Oct 31, 2023

Breast Cancer Trial in Worldwide (Dato-DXd, Durvalumab, Capecitabine)

Recruiting
  • Breast Cancer
  • Gilbert, Arizona
  • +165 more
Jan 17, 2023

Breast Cancer Trial in Worldwide (Dato-DXd, Paclitaxel, Nab-paclitaxel)

Recruiting
  • Breast Cancer
  • Duarte, California
  • +260 more
Jan 19, 2023

Advanced or Metastatic NSCLC Trial in Worldwide (Datopotamab deruxtecan, Pembrolizumab, Carboplatin)

Recruiting
  • Advanced or Metastatic NSCLC
  • Datopotamab deruxtecan
  • +3 more
  • Scottsdale, Arizona
  • +24 more
Jun 3, 2022

Metastatic Non Small Cell Lung Cancer Trial in Japan (Datopotamab Deruxtecan, Pembrolizumab, Pemetrexed)

Recruiting
  • Metastatic Non Small Cell Lung Cancer
  • Datopotamab Deruxtecan
  • +4 more
  • Fukuoka, Japan
  • +3 more
Jan 13, 2023

Advanced or Metastatic NSCLC Trial in Worldwide (Datopotamab deruxtecan, Durvalumab, Carboplatin)

Recruiting
  • Advanced or Metastatic NSCLC
  • Datopotamab deruxtecan
  • +4 more
  • Santa Ana, California
  • +15 more
Dec 13, 2022

Metastatic Non Small Cell Lung Cancer Trial in Worldwide (Datopotamab Deruxtecan, Pembrolizumab)

Recruiting
  • Metastatic Non Small Cell Lung Cancer
  • Chandler, Arizona
  • +32 more
Aug 12, 2022

Medial Tibial Stress Syndrome Trial (Functional strength training of hip abductors, A selected physical therapy exercise

Not yet recruiting
  • Medial Tibial Stress Syndrome
  • Functional strength training of hip abductors
  • A selected physical therapy exercise program
  • (no location specified)
Dec 2, 2022

Quality of Life and Life Satisfaction in Pediatric and

Recruiting
  • Musculoskeletal Injury
  • Quality of Life
    • Denver, Colorado
      Children's Hospital Colorado
    Jan 6, 2022

    Ischemic and Non-ischemic Cardiomyopathy Trial in Rochester, Tel HaShomer (Medtronic ICD with Opti Vol-Monitor)

    Recruiting
    • Ischemic and Non-ischemic Cardiomyopathy
    • Medtronic ICD with Opti Vol-Monitor
    • Rochester, New York
    • +1 more
    Mar 9, 2022

    Anterior Cruciate Ligament Injuries Trial in Ciudad de Mexico (Neuromuscular exercise program, Institutional exercise program)

    Recruiting
    • Anterior Cruciate Ligament Injuries
    • Neuromuscular exercise program
    • Institutional exercise program
    • Ciudad de Mexico, Mexico
      National Institute of Rehabilitation
    Apr 12, 2023

    Atherosclerosis of Artery, Peripheral Artery Disease, Diabetes Trial in Changsha, Jinan (N-acetylcysteine, Placebo)

    Withdrawn
    • Atherosclerosis of Artery
    • +4 more
    • Changsha, Hunan, China
    • +1 more
    Jun 9, 2023

    Ankle Sprain, Ankle Sprain 1St Degree, Ankle Sprain 2Nd Degree Trial in Iztacalco (telerehabilitation)

    Completed
    • Ankle Sprain
    • +2 more
    • telerehabilitation
    • Iztacalco, Ciudad De México, Mexico
      Unidad de Medicina Familiar 21
    Jan 17, 2023

    Central Serous Chorioretinopathy Trial in Hong Kong

    Recruiting
    • Central Serous Chorioretinopathy
      • Hong Kong, Hong Kong
      • +2 more
      Apr 19, 2022

      Liquid biopsY Based cfDNA Methylation and pRotEin biomArKers for

      Recruiting
      • Cancer
        • Shanghai, Shanghai, China
          Shanghai Changhai Hospital
        Aug 9, 2022